Growth hormone treatment does not augment the anti‐diabetic effects of liraglutide in UCD‐T2DM rats

Growth hormone treatment does not augment the anti‐diabetic effects of liraglutide in UCD‐T2DM rats

Abstract Introduction The incretin hormone glucagon‐like peptide‐1 (GLP‐1) slows gastric emptying, increases satiety and enhances insulin secretion. GLP‐1 receptor agonists, such as liraglutide, are used therapeutically in humans to improve glycaemic control and delay the onset of type 2 diabetes me...

Full description

Bibliographic Details
Main Authors:	Michael M. Swarbrick, Chad L. Cox, James L. Graham, Lotte B. Knudsen, Kimber Stanhope, Kirsten Raun, Peter J. Havel
Format:	Article
Language:	English
Published:	Wiley 2023-01-01
Series:	Endocrinology, Diabetes & Metabolism
Subjects:	diabetes mellitus food intake growth hormone insulin liraglutide obesity
Online Access:	https://doi.org/10.1002/edm2.392

Similar Items

Potentiation of Acetylcholine-Induced Relaxation of Aorta in Male UC Davis Type 2 Diabetes Mellitus (UCD-T2DM) Rats: Sex-Specific Responses
by: Farjana Akther, et al.
Published: (2021-07-01)

Liraglutide overdose: A case report and an updated review
by: Sharafaldeen Bin Nafisah, et al.
Published: (2020-01-01)

Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study
by: Hirotatsu Nakaguchi, et al.
Published: (2020-11-01)

Comparison of Postprandial Insulin Levels in Withania Coagulans and Liraglutide Treated Diabetic Rats
by: Abdul Samad, Shazia Ali, Noman Sadiq
Published: (2018-12-01)

The Discovery and Development of Liraglutide and Semaglutide
by: Lotte Bjerre Knudsen, et al.
Published: (2019-04-01)

Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
by: Minze MG, et al.
Published: (2016-03-01)

Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2017-06-01)

Liraglutide attenuates atherosclerosis via inhibiting ER-induced macrophage derived microvesicles production in T2DM rats
by: Jinjin Li, et al.
Published: (2017-12-01)

Evaluation of Liraglutide Effect on Serum Adipocytokines of Adults Male Wistar Rats with Insulin Resistance That Induced by High Fat Diet
by: Furqan Mohammed Abdulellah, et al.
Published: (2018-12-01)

Hippocampal Ganglioside Composition is Altered by Metformin and Liraglutide Treatment in A High-Fat High-Sugar Diet Rat Model
by: Marin Kuharić, et al.
Published: (2023-01-01)

A review of the efficacy and safety of the finished fixed-ratio combination of insulin degludec and liraglutide in the treatment of type 2 diabetes mellitus
by: A. S. Pogorelova
Published: (2018-07-01)

Liraglutide Attenuates Glucolipotoxicity-Induced RSC96 Schwann Cells’ Inflammation and Dysfunction
by: Edy Kornelius, et al.
Published: (2022-09-01)

Liraglutide Drug Loading with Double Layered Hydroxide- Synthesis and Characterization
by: Sevan Adeeb Doshan, et al.
Published: (2020-06-01)

Association of serum fetuin-B with insulin resistance and pre-diabetes in young Chinese women: evidence from a cross-sectional study and effect of liraglutide
by: Xuyun Xia, et al.
Published: (2021-08-01)

Liraglutide and Exercise: A Possible Treatment for Obesity?
by: Ana Paula Azevêdo Macêdo, et al.
Published: (2022-08-01)

Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
by: Li Chun-jun, et al.
Published: (2012-11-01)

Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes
by: Christian Stevns Hansen, et al.
Published: (2019-04-01)

Efficacy and safety of liraglutide in Indian adolescents with obesity
by: I. S. Kochar, et al.
Published: (2019-06-01)

Ejaculate quality indicators of men with asthenozoospermia and asthenoteratozoospermia by treatment of obesity with liraglutide
by: D. N. Bobkov, et al.
Published: (2021-10-01)

Preoperative liraglutide modulates control of fat and glucose metabolism during cardiopulmonary bypass surgery
by: Robert van Wilpe, et al.
Published: (2025-02-01)

Liraglutide and Insulin Have Contrary Effects on Adipogenesis of Human Adipose-Derived Stem Cells via Wnt Pathway
by: Liu H, et al.
Published: (2020-09-01)

Efficacy and safety of the fixed‐ratio combination of insulin degludec and liraglutide by baseline glycated hemoglobin, body mass index and age in Japanese individuals with type 2 diabetes: A subgroup analysis of two phase III trials
by: Mitsuhisa Komatsu, et al.
Published: (2021-09-01)

Role of liraglutide in Alzheimer’s disease pathology
by: Maria Vargas-Soria, et al.
Published: (2021-06-01)

Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway
by: Yang P, et al.
Published: (2019-07-01)

Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting
by: Parjeet Kaur, et al.
Published: (2016-01-01)

Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction
by: Qi Q, et al.
Published: (2017-07-01)

Comparison of the effects of liraglutide and sibutramine in obese patients
by: G. A. Matveev, et al.
Published: (2021-07-01)

Continuation of Liraglutide during Fasting is not Associated with Hypoglycaemia
by: Rosalie Koot, et al.
Published: (2017-10-01)

Clinical Impact of Liraglutide as a Treatment of Obesity
by: Alruwaili H, et al.
Published: (2021-03-01)

Histopathological Study of Liraglutide on Renal Deterioration Progression Induced by Doxorubicin
by: Hayder Hussein Luaibi, et al.
Published: (2019-12-01)

Investigation of Liraglutide Effects on Changes of Uterine Tissue and Estradiol and FSH Hormones in NMRI Mice
by: Sara Atashnezhad, et al.
Published: (2017-06-01)

The effects of liraglutide on the characteristics of blood parameters and testicular tissue induced diabetes and obesity in mice
by: Saied Mohammadzadeh, et al.
Published: (2024-08-01)

Low dose liraglutide in Indian patients with type 2 diabetes in the real world setting
by: Debmalya Sanyal, et al.
Published: (2013-01-01)

Obezitenin Medikal Tedavisinde Liraglutide Etkinliğinin Araştırılması
by: Murat Kose, et al.
Published: (2023-09-01)

United States experience of insulin Degludec alone or in combination for type 1 and type 2 diabetes
by: Rendell M
Published: (2017-04-01)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)

Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
by: Damien Denimal, et al.
Published: (2023-05-01)

Adropin – Potential Link in Cardiovascular Protection for Obese Male Type 2 Diabetes Mellitus Patients Treated with Liraglutide
by: Tina Tičinović Kurir, et al.
Published: (2020-01-01)

Liraglutide; A New Hope for Obese Diabetics
by: Ajeet Kumar, et al.
Published: (2020-12-01)

Complex vasoactivity of liraglutide. Contribution of three gasotransmitters
by: Eszter Sélley, et al.
Published: (2015-05-01)